What are the implications of a Transferrin Saturation (TSAT) level of 24.0 in a patient with Chronic Kidney Disease (CKD) stage 2, impaired cardiac function, and symptoms of fatigue and shortness of breath?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 1, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

TSAT of 24% in CKD Stage 2: Clinical Significance

Your TSAT of 24% is above the critical threshold of 20% and suggests adequate iron availability for red blood cell production, though given your symptoms of fatigue and shortness of breath with impaired cardiac function, you may still have functional iron deficiency that warrants further evaluation. 1

Understanding the 20% Threshold

The 20% TSAT cutoff is not a sharp dividing line between adequate and inadequate iron status 1:

  • TSAT ≥20% does NOT guarantee you have sufficient iron - Many CKD patients with TSAT >20% can still be functionally iron deficient and may respond to additional iron therapy with improved hemoglobin or reduced need for erythropoiesis-stimulating agents (ESAs) if you're on them 1

  • The lower the TSAT, the higher the likelihood of iron deficiency - While your 24% is above the threshold, it's still in the lower range, and the probability of functional iron deficiency increases as TSAT approaches 20% 1

Why Your Symptoms Matter More Than the Number

Your fatigue and shortness of breath are critical context - Recent evidence shows that TSAT levels ≤20% are independently associated with worse physical health-related quality of life and reduced ability to perform intense physical activity in non-dialysis CKD patients, even after accounting for hemoglobin levels 2. Your TSAT of 24% places you just above this threshold, but your symptoms suggest you may still be experiencing iron-related functional limitations.

Cardiac implications are particularly important - In heart failure patients (relevant given your impaired cardiac function), low TSAT is significantly associated with adverse outcomes including death and HF-related admissions, with stronger associations in patients with preserved ejection fraction 3. TSAT appears to be a more reliable prognostic marker than ferritin in cardiac patients 3.

What You Need to Check Next

You must know your ferritin level to properly interpret your TSAT 1:

  • If your ferritin is <100 ng/mL with TSAT 24%: You have absolute iron deficiency and should receive iron supplementation 1

  • If your ferritin is 100-300 ng/mL with TSAT 24%: You may have functional iron deficiency, especially if you're anemic or on ESAs 1

  • If your ferritin is >300 ng/mL with TSAT 24%: This pattern suggests either functional iron deficiency OR an inflammatory iron block 1

Distinguishing Functional Iron Deficiency from Inflammation

This is a common clinical challenge when TSAT is borderline and ferritin is elevated 1:

  • Functional iron deficiency pattern: Serial ferritin levels decrease during ESA therapy but remain >100 ng/mL 1

  • Inflammatory iron block pattern: Abrupt increase in ferritin associated with sudden drop in TSAT 1

  • Diagnostic trial approach: If unclear, give weekly IV iron (50-125 mg) for 8-10 doses - if no erythropoietic response occurs, inflammatory block is most likely and further iron should be withheld until inflammation resolves 1

  • Consider checking C-reactive protein to assess inflammatory contribution to your iron parameters 1, 4

Clinical Decision Algorithm for Your Situation

Given your CKD stage 2 with cardiac dysfunction and symptoms:

  1. Obtain ferritin level immediately if not already available 1

  2. Check hemoglobin to assess if you're anemic (this drives treatment decisions) 1, 5

  3. If anemic with TSAT 24% and ferritin <100 ng/mL: Start iron supplementation (oral may be sufficient in CKD stage 2) 1, 6

  4. If anemic with TSAT 24% and ferritin 100-300 ng/mL: Consider trial of iron therapy, as you may have functional iron deficiency 1

  5. If anemic with TSAT 24% and ferritin >300 ng/mL: Check inflammatory markers and consider diagnostic trial of IV iron as described above 1, 4

Important Caveats

Transferrin saturation is more reliable than ferritin in CKD because ferritin is an acute-phase reactant that rises with inflammation independent of actual iron stores 1, 4. This is particularly relevant in CKD where chronic inflammation is common 4.

Your measurement was "a few months ago" - Iron parameters should be rechecked, especially if your symptoms have worsened or if you've started any new treatments 1. In stable CKD patients, TSAT and ferritin should be monitored at least every 3 months 4.

The difference between 20% and 24% is clinically small - Don't be falsely reassured by being "just above" the threshold, especially given your symptomatic presentation 1. The guidelines acknowledge that no single TSAT value perfectly discriminates between patients who are or are not functionally iron deficient 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Serum biomarkers of iron stores are associated with worse physical health-related quality of life in nondialysis-dependent chronic kidney disease patients with or without anemia.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2021

Guideline

Ferritin Levels in Chronic Kidney Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.